639P - Volume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery?

S Nagasawa,T Ogata,K Hara,Y Shimoda,M Nakazono,Y Kumazu,T Hayashi,T Yamada,Y Rino,M Masuda,T Yoshikawa,T Oshima

doi:10.1093/annonc/mdy282.023

639P - Volume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery?

S Nagasawa, T Ogata + Show 10 more

Open Access

https://doi.org/10.1093/annonc/mdy282.023

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Oct 1, 2018
License type: publisher-specific-oa

Affiliation: Kanagawa Prefectural Hospital Organization, Yokohama City University, National Cancer Center Hospital East

#Surrogate End Point For Survival #Reduction Rate Of Tumor + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

639P - Volume reduction rate of the primary tumor of esophageal squamous cell carcinoma after neoadjuvant chemotherapy: Could this measurement be a surrogate end point for survival before surgery?

Full Text